Senior Software Engineer, Pattern Bioscience
C++
+ Equity
Combatting antibiotic resistance
Be an early applicant
Combatting antibiotic resistance
21-100 employees
Be an early applicant
+ Equity
21-100 employees
Company mission
To advance single-cell microbiology to make targeted antimicrobial treatment informatio available days sooner.
Role
Who you are
- Are a C++ Expert: You are a specialist in C++ and possess strong fundamentals in computer science and multi-threaded development
- Are "Multilingual" across the Stack: You are fluent enough in Python (NumPy, SciPy, Pandas) to work across our stack and have experience exposing C++ APIs to other languages
- Are at Home in Linux: You are comfortable working with Linux and Docker to manage our development and deployment environments
- Can Navigate Uncharted Code: You have the patience and skill to inherit a complex codebase, deconstruct its architecture, and the vision to make it better
- Thrive on Multidisciplinary Teams: You enjoy solving problems at the intersection of software and physical hardware, translating raw data into clinical results
- Adapt Quickly: You are energized by the high-intensity, "tight-knit" nature of a startup where the team values excellence and has a low tolerance for inefficiency
Desirable
- Professional Experience: A minimum of 5 years of industry experience in a software environment heavily oriented toward C++
- Systems Fluency: Deep understanding of distributed systems and managing large, complex datasets
- Hardware Interface Experience: Experience dealing with hardware control or real-time data processing is a significant advantage
- Startup Experience: You thrive in environments with high individual ownership and fast iteration cycles; previous startup experience is a plus
What the job involves
- We're looking for a Senior Software Engineer to own and advance that software
- The codebase has history; part of the job is understanding it well enough to extend it without breaking things that matter. You'll work across a multidisciplinary team; firmware engineers, data scientists, and biologists, collaborating at the intersection of software and physical systems
- Architect & Evolve Core C++ Systems: Take ownership of the existing, high-performance C++ codebase that powers our diagnostic instruments and is core to our product
- Deconstruct & Scale Complex Code: Dive deep into a non-trivial codebase to understand its history, add critical new functionality, and ensure the software remains robust as we scale
- Bridge the Gap Between Hardware & Data: Collaborate across a multidisciplinary team to manage hardware interfaces, timing constraints, and real-time data pipelines
- Drive High-Output Engineering: Act as a fundamental contributor within a small, potent team, delivering technical solutions with a level of speed and precision that outpaces traditional engineering teams
Our take
Pattern Bioscience aims to make a significant impact in the battle against antibiotic-resistant infections, which have long been recognized as detrimental to our health and a major financial burden on the healthcare system.
It uses single-cell technology, eliminating the need for time-consuming bacterial cultures. This approach provides healthcare professionals with rapid and accurate information, enabling them to promptly prescribe the most effective antibiotics for their patients.
With investments from multiple organizations, Pattern Bioscience has been able to successfully develop its infectious disease diagnostic platform. While its initial focus was on pneumonia testing, the company achieved a significant milestone in 2021 when the FDA granted it breakthrough status. Currently, it is expanding its platform capabilities to enable a range of infectious disease tests in order to enhance its ability to address diverse medical challenges.
Freddie
Company Specialist at Welcome to the Jungle
Company
Funding (last 2 of 6 rounds)
Nov 2025
$43m
SERIES D
Apr 2023
$28.7m
SERIES C
Total funding: $92m
Company HQ
Congress Avenue Historic District, Austin, TX
Leadership
Nicolas Arab
(Co-Founder & CTO)Previously worked at Luminex in various roles, including Electrical Engineering Manager and Senior Director of Advanced Technology.
Ross Johnson
(Co-Founder & Chief Engineer)Graduated from the University of Texas with an Masters in Mechanical Engineering. Previously worked at Luminex as a Mechanical Engineer.
Carey-Ann Burnham
(CEO)Initially joined Pattern Bioscience as CCO in 2022, becoming CEO in 2025. She has also been at the American Society for Microbiology since 2014, currently serving as an Editor in Chief for ASM Case Reports. Alongside this, she has been at Washington University School of Medicine in St. Louis since 2007, currently serving as a Professor of Pathology & Immunology, Molecular Microbiology, Pediatrics, and Medicine.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job